Manuel Benavente Loayza
About Manuel Benavente Loayza
Manuel Benavente Loayza is an MBA R&D Leadership Development Program Associate at Bristol-Myers Squibb in New Jersey, USA.
Title
Manuel Benavente Loayza currently holds the position of MBA R&D Leadership Development Program Associate at Bristol-Myers Squibb. His current role focuses on research and development leadership within the New Jersey, USA office.
Current Company
Manuel Benavente Loayza is currently employed at Bristol-Myers Squibb, a global biopharmaceutical company, where he serves as an MBA R&D Leadership Development Program Associate. His role is based in New Jersey, USA.
Past Work Experience
Manuel Benavente Loayza has a diverse background in management and operations. He previously worked at La Positiva Seguros in Lima, Peru, as a Supplier Management and Expenditure Control Manager from 2012 to 2014. Prior to that, he held dual roles at FARMINDUSTRIA S.A.; he was a Purchasing Manager in 2011-2012 and a Purchaser from 2006 to 2010. Additionally, he completed an MBA R&D internship at Bristol-Myers Squibb focusing on Vendor and Outsourcing Management in 2016.
Educational Background
Manuel Benavente Loayza has a rich educational history. He earned a Master of Business Administration (MBA) from the University of North Carolina at Chapel Hill in 2017. Furthermore, he completed an Advanced Program in Logistics and Operations Management from Universidad ESAN in 2012. His foundational education includes a Bachelor of Science (B.S.) in Industrial Engineering from Universidad de Lima, achieved in 2004.
Achievements at Bristol-Myers Squibb
During his tenure at Bristol-Myers Squibb, Manuel Benavente Loayza made significant contributions. In his first rotation, he created a vendor utilization analysis process and dashboard for clinical development categories. His second rotation focused on redefining the Translational Medicine biomarker work portfolio budgeting process and implementing supporting tools. In the third rotation, he developed a Total Cost of Ownership model and financial tool for laboratory instruments, proposed actions to shift tail expenditure towards preferred suppliers for the Laboratory Consumables category, and designed a dashboard for capital investment data analysis.